These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

231 related items for PubMed ID: 12552362

  • 1. Attenuation of hypothalamic-pituitary-adrenocortical hyperactivity in depressed patients by mirtazapine.
    Schüle C, Baghai T, Zwanzger P, Ella R, Eser D, Padberg F, Möller HJ, Rupprecht R.
    Psychopharmacology (Berl); 2003 Mar; 166(3):271-5. PubMed ID: 12552362
    [Abstract] [Full Text] [Related]

  • 2. Time course of hypothalamic-pituitary-adrenocortical axis activity during treatment with reboxetine and mirtazapine in depressed patients.
    Schüle C, Baghai TC, Eser D, Zwanzger P, Jordan M, Buechs R, Rupprecht R.
    Psychopharmacology (Berl); 2006 Jul; 186(4):601-11. PubMed ID: 16758243
    [Abstract] [Full Text] [Related]

  • 3. Attenuation of HPA axis hyperactivity and simultaneous clinical deterioration in a depressed patient treated with mirtazapine.
    Schüle C, Baghai T, Zwanzger P, Rupprecht R.
    World J Biol Psychiatry; 2001 Apr; 2(2):103-5. PubMed ID: 12587193
    [Abstract] [Full Text] [Related]

  • 4. Suppressive effect of mirtazapine on the HPA system in acutely depressed women seems to be transient and not related to antidepressant action.
    Horstmann S, Dose T, Lucae S, Kloiber S, Menke A, Hennings J, Spieler D, Uhr M, Holsboer F, Ising M.
    Psychoneuroendocrinology; 2009 Feb; 34(2):238-248. PubMed ID: 18926641
    [Abstract] [Full Text] [Related]

  • 5. Neuroendocrinological mechanisms of actions of antidepressant drugs.
    Schüle C.
    J Neuroendocrinol; 2007 Mar; 19(3):213-26. PubMed ID: 17280595
    [Abstract] [Full Text] [Related]

  • 6. Combined dexamethasone suppression-corticotrophin-releasing hormone stimulation test in medication-free major depression and healthy volunteers.
    Sher L, Oquendo MA, Burke AK, Cooper TB, Mann JJ.
    J Affect Disord; 2013 Dec; 151(3):1108-12. PubMed ID: 23866302
    [Abstract] [Full Text] [Related]

  • 7. Pharmacological and nonpharmacological factors influencing hypothalamic-pituitary-adrenocortical axis reactivity in acutely depressed psychiatric in-patients, measured by the Dex-CRH test.
    Künzel HE, Binder EB, Nickel T, Ising M, Fuchs B, Majer M, Pfennig A, Ernst G, Kern N, Schmid DA, Uhr M, Holsboer F, Modell S.
    Neuropsychopharmacology; 2003 Dec; 28(12):2169-78. PubMed ID: 12931142
    [Abstract] [Full Text] [Related]

  • 8. Mirtazapine does not influence tetrahydrodeoxycorticosterone levels in depressed patients.
    Schüle C, Baghai TC, di Michele F, Eser D, Pasini A, Romeo E, Rupprecht R.
    World J Biol Psychiatry; 2010 Mar; 11(2 Pt 2):308-13. PubMed ID: 20218794
    [Abstract] [Full Text] [Related]

  • 9. HPA-axis regulation at in-patient admission is associated with antidepressant therapy outcome in male but not in female depressed patients.
    Binder EB, Künzel HE, Nickel T, Kern N, Pfennig A, Majer M, Uhr M, Ising M, Holsboer F.
    Psychoneuroendocrinology; 2009 Jan; 34(1):99-109. PubMed ID: 18829172
    [Abstract] [Full Text] [Related]

  • 10. Long-term citalopram administration reduces responsiveness of HPA axis in patients with major depression: relationship with S-citalopram concentrations in plasma and cerebrospinal fluid (CSF) and clinical response.
    Nikisch G, Mathé AA, Czernik A, Thiele J, Bohner J, Eap CB, Agren H, Baumann P.
    Psychopharmacology (Berl); 2005 Oct; 181(4):751-60. PubMed ID: 15988572
    [Abstract] [Full Text] [Related]

  • 11. Changes of sleep architecture, spectral composition of sleep EEG, the nocturnal secretion of cortisol, ACTH, GH, prolactin, melatonin, ghrelin, and leptin, and the DEX-CRH test in depressed patients during treatment with mirtazapine.
    Schmid DA, Wichniak A, Uhr M, Ising M, Brunner H, Held K, Weikel JC, Sonntag A, Steiger A.
    Neuropsychopharmacology; 2006 Apr; 31(4):832-44. PubMed ID: 16237393
    [Abstract] [Full Text] [Related]

  • 12. Cortisol response patterns in depressed women and their healthy daughters at risk: Comparison with healthy women and their daughters.
    Gonul AS, Cetinkalp S, Tunay S, Polat I, Simsek F, Aksoy B, Kizilates G, Erdogan Y, Coburn KL.
    J Psychiatr Res; 2017 Feb; 85():66-74. PubMed ID: 27837659
    [Abstract] [Full Text] [Related]

  • 13. Influence of mirtazapine on salivary cortisol in depressed patients.
    Laakmann G, Hennig J, Baghai T, Schüle C.
    Neuropsychobiology; 2003 Feb; 47(1):31-6. PubMed ID: 12606843
    [Abstract] [Full Text] [Related]

  • 14. Assessment of the dexamethasone/CRH test as a state-dependent marker for hypothalamic-pituitary-adrenal (HPA) axis abnormalities in major depressive episode: a Multicenter Study.
    Kunugi H, Ida I, Owashi T, Kimura M, Inoue Y, Nakagawa S, Yabana T, Urushibara T, Kanai R, Aihara M, Yuuki N, Otsubo T, Oshima A, Kudo K, Inoue T, Kitaichi Y, Shirakawa O, Isogawa K, Nagayama H, Kamijima K, Nanko S, Kanba S, Higuchi T, Mikuni M.
    Neuropsychopharmacology; 2006 Jan; 31(1):212-20. PubMed ID: 16123748
    [Abstract] [Full Text] [Related]

  • 15. Effects of escitalopram/quetiapine combination therapy versus escitalopram monotherapy on hypothalamic-pituitary-adrenal-axis activity in relation to antidepressant effectiveness.
    Nothdurfter C, Schmotz C, Sarubin N, Baghai TC, Laenger A, Lieb M, Bondy B, Rupprecht R, Schüle C.
    J Psychiatr Res; 2014 May; 52():15-20. PubMed ID: 24513501
    [Abstract] [Full Text] [Related]

  • 16. Sleep deprivation and hypothalamic-pituitary-adrenal (HPA) axis activity in depressed patients.
    Schüle C, Baghai T, Zwanzger P, Minov C, Padberg F, Rupprecht R.
    J Psychiatr Res; 2001 May; 35(4):239-47. PubMed ID: 11578642
    [Abstract] [Full Text] [Related]

  • 17. Mirtazapine acutely inhibits salivary cortisol concentrations in depressed patients.
    Laakmann G, Hennig J, Baghai T, Schüle C.
    Ann N Y Acad Sci; 2004 Dec; 1032():279-82. PubMed ID: 15677428
    [Abstract] [Full Text] [Related]

  • 18. Hypothalamic-pituitary-adrenocortical axis dysregulation in patients with major depression is influenced by the insertion/deletion polymorphism in the angiotensin I-converting enzyme gene.
    Baghai TC, Schule C, Zwanzger P, Minov C, Zill P, Ella R, Eser D, Oezer S, Bondy B, Rupprecht R.
    Neurosci Lett; 2002 Aug 16; 328(3):299-303. PubMed ID: 12147330
    [Abstract] [Full Text] [Related]

  • 19. Impaired hypothalamic-pituitary-adrenocortical (HPA) system is related to severity of benzodiazepine withdrawal in patients with depression.
    Wichniak A, Brunner H, Ising M, Pedrosa Gil F, Holsboer F, Friess E.
    Psychoneuroendocrinology; 2004 Oct 16; 29(9):1101-8. PubMed ID: 15219633
    [Abstract] [Full Text] [Related]

  • 20. Longitudinal neuroendocrine changes assessed by dexamethasone/CRH and growth hormone releasing hormone tests in psychotic depression.
    Owashi T, Otsubo T, Oshima A, Nakagome K, Higuchi T, Kamijima K.
    Psychoneuroendocrinology; 2008 Feb 16; 33(2):152-61. PubMed ID: 18068306
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.